CD34 and type 2 diabetes mellitus: Herein, in order to explore if a transcriptional signature predictive of immune cell dysfunction was already present in HSPCs of DM patients, we compared the transcripts of CD34+ HSPCs isolated from sternal BM biopsies of CAD patients with or without T2DM by genome-wide expression analyses.